Bladder cancer is a type of malignant tumor, and survival time generally varies greatly for each individual with different health conditions, severity of bladder cancer, and treatment modalities. The common standard is to use the 5-year survival rate to express the bladder cancer survival problem. The 5-year survival rate means the percentage of all patients with bladder cancer who survive for 5 years out of the total number of patients. In general, the deeper the cancerous tissue is infiltrated, the lower the 5-year survival rate, and the more organs that have metastasized, the lower the 5-year survival rate. This essentially brings us to the issue of bladder cancer staging, which generally refers to the most advanced bladder cancer as stage 4 and bladder cancer with mucosal infiltration alone as stage 0. Stage I, II, and III are used to describe the various different conditions of cancerous tissue infiltration such as deeper infiltration in between and the appearance of lymphatic metastases. Current statistics show that the 5-year relative survival rate of bladder cancer is about 98% for patients with stage 0 bladder cancer, 88% for patients with stage I bladder cancer, 63% for stage II bladder cancer, and 46% for stage III bladder cancer. Of course, the 5-year survival rate is a general statistic, and not everyone lives that long, depending on the individual patient. The most effective way to prolong life after developing bladder cancer is to achieve early detection of the disease, early treatment as possible and standardized treatment.